Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,600
Closed -$744K 5544
2025
Q3
$744K Sell
8,600
-2,200
-20% -$174K ﹤0.01% 3550
2025
Q2
$824K Buy
+10,800
New +$790K ﹤0.01% 3466
2025
Q1
Sell
-24,000
Closed -$1.88M 5455
2024
Q4
$1.88M Buy
+24,000
New +$2.24M ﹤0.01% 2934

Other funds holding NUVL

Barclays's NUVL Position: Q1 2026 in Review

Barclays reduced its Nuvalent (NUVL) stake by 75% in Q1 2026, selling an estimated $9.63M and leaving 30,844 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Barclays first reported a position in NUVL in Q1 2022 and has held it in 17 quarters since. The position peaked at $12.6M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Barclays held 30,844 shares of Nuvalent worth $3.16M as of Q1 2026.
  • Barclays sold 94,484 Nuvalent shares in Q1 2026, an estimated $9.63M.
  • Nuvalent made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2094 holding.
  • Barclays first reported a position in Nuvalent in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Nuvalent position peaked at $12.6M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.